Clinical Trial: Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above

U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07289542) titled 'Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above' on Dec. 04.

Brief Summary: The primary objective of this study is to evaluate the immunogenicity and safety of a single injection of two dose levels of ABO1105 in adults aged 50 years or above.

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: Respiratory Syncytial Virus

Intervention: BIOLOGICAL: ABO1105

Formulation for injection

DRUG: Placebo

0.9% sodium chloride (normal saline) injection

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Suzhou Abogen Biosciences Co., Ltd.

Disclaimer: Curated...